Health Canada
Symbol of the Government of Canada
First Nations, Inuit and Aboriginal Health

Drug Benefit List - April 2009

08:00 ANTI-INFECTIVE AGENTS

08:08.00 ANTHELMINTICS

MEBENDAZOLE

100MG Tablet
00556734 VERMOX JNO

PYRANTEL PAMOATE

50MG/ML Suspension
01944355 COMBANTRIN PFI
125MG Tablet
01944363 COMBANTRIN PFI

PYRVINIUM PAMOATE

10MG/ML Suspension
02019809 VANQUIN WLA

08:12.06 CEPHALOSPORINS

CEFACLOR

250MG Capsule
02230263 APO-CEFACLOR APX
00465186 CECLOR PHH
02177633 DOM-CEFACLOR DPC
02231691 NOVO-CEFACLOR NOP
02231432 NU-CEFACLOR NXP
02238200 PDL-CEFACLOR PDL
02237729 SCHEIN-CEFACLOR SCN
500MG Capsule
02230264 APO-CEFACLOR APX
00465194 CECLOR PHH
02177641 DOM-CEFACLOR DPC
02231693 NOVO-CEFACLOR NOP
02231433 NU-CEFACLOR NXP
02238201 PDL-CEFACLOR PDL
02237730 SCHEIN-CEFACLOR SCN
25MG/ML Suspension
02237500 APO-CEFACLOR APX
00465208 CECLOR PHH
02177668 DOM-CEFACLOR DPC
02238202 PDL-CEFACLOR PDL
50MG/ML Suspension
02237501 APO-CEFACLOR APX
00465216 CECLOR PHH
02177676 DOM-CEFACLOR DPC
02238203 PDL-CEFACLOR PDL
75MG/ML Suspension
02237502 APO-CEFACLOR APX
00832804 CECLOR BID PHH
02177684 DOM-CEFACLOR DPC
02238204 PDL-CEFACLOR PDL

CEFADROXIL

500MG Capsule
02240774 APO-CEFADROXIL APX
00507245 DURICEF BMS
02235134 NOVO-CEFADROXIL NOP
02311062 PRO-CEFADROXIL PDL

CEFIXIME

20MG/ML Suspension
00868965 SUPRAX SAC
400MG Tablet
00868981 SUPRAX SAC

CEFPROZIL

25MG/ML Suspension
02293943 APO-CEFPROZIL APX
02163675 CEFZIL BMS
02303426 SANDOZ CEFPROZIL SDZ
50MG/ML Suspension
02293951 APO-CEFPROZIL APX
02163683 CEFZIL BMS
02293579 RAN-CEFPROZIL RBY
02303434 SANDOZ CEFPROZIL SDZ
250MG Tablet
02292998 APO-CEFPROZIL APX
02163659 CEFZIL BMS
02293528 RAN-CEFPROZIL RBY
02302179 SANDOZ CEFPROZIL SDZ
500MG Tablet
02293005 APO-CEFPROZIL APX
02163667 CEFZIL BMS
02293536 RAN-CEFPROZIL RBY
02302187 SANDOZ CEFPROZIL SDZ

CEFUROXIME AXETIL

25MG/ML Suspension
02212307 CEFTIN GSK
250MG Tablet
02244393 APO-CEFUROXIME APX
02212277 CEFTIN GSK
02242656 RATIO-CEFUROXIME RPH
500MG Tablet
02244394 APO-CEFUROXIME APX
02212285 CEFTIN GSK
02311453 PRO-CEFUROXIME PDL
02242657 RATIO-CEFUROXIME RPH

CEPHALEXIN

250MG Capsule
00342084 NOVO-LEXIN NOP
500MG Capsule
00342114 NOVO-LEXIN NOP
25MG/ML Suspension
02177862 DOM-CEPHALEXIN DPC
00342106 NOVO-LEXIN NOP
50MG/ML Suspension
02177870 DOM-CEPHALEXIN DPC
00342092 NOVO-LEXIN NOP
250MG Tablet
00768723 APO-CEPHALEX APX
02177846 DOM-CEPHALEXIN DPC
00583413 NOVO-LEXIN NOP
00865877 NU-CEPHALEX NXP
00828858 PDL-CEPHALEXIN PDL
02177781 PMS-CEPHALEXIN PMS
500MG Tablet
00768715 APO-CEPHALEX APX
02177854 DOM-CEPHALEXIN DPC
00583421 NOVO-LEXIN NOP
00865885 NU-CEPHALEX NXP
00828866 PDL-CEPHALEXIN PDL
02177803 PMS-CEPHALEXIN PMS

08:12.12 MACROLIDES

AZITHROMYCIN

20MG/ML Suspension
02315157 NOVO-AZITHROMYCIN NOP
02274388 PMS-AZITHROMYCIN PMS
02223716 ZITHROMAX PFI
40MG/ML Suspension
02315165 NOVO-AZITHROMYCIN NOP
02274396 PMS-AZITHROMYCIN PMS
02223724 ZITHROMAX PFI
250MG Tablet
02247423 APO-AZITHROMYCIN APX
02255340 CO-AZITHROMYCIN COB
02278359 GEN-AZITHROMYCIN GEN
02267845 NOVO-AZITHROMYCIN NOP
02261634 PMS-AZITHROMYCIN PMS
02310600 PRO-AZITHROMYCIN PDL
02275287 RATIO-AZITHROMYCIN RPH
02275309 RIVA-AZITHROMYCIN RIV
02265826 SANDOZ-AZITHROMYCIN SDZ
02212021 ZITHROMAX PFI
600MG Tablet
02256088 CO-AZITHROMYCIN COB
02261642 PMS-AZITHROMYCIN PMS
02275317 RIVA-AZITHROMYCIN RIV
02231143 ZITHROMAX PFI

CLARITHROMYCIN

500MG Extended Release Tablet
02244756 BIAXIN XL ABB
250MG Film Coated Tablet
02274744 APO-CLARITHROMYCIN APX
01984853 BIAXIN ABB
02248856 GEN-CLARITHROMYCIN GEN
02247573 PMS-CLARITHROMYCIN PMS
02247818 RATIO-CLARITHROMYCIN RPH
02266539 SANDOZ-CLARITHROMYCIN RHO
500MG Film Coated Tablet
02266547 SANDOZ-CLARITHROMYCIN RHO
02274752 APO-CLARITHROMYCIN APX
02126710 BIAXIN ABB
02248857 GEN-CLARITHROMYCIN GEN
02247574 PMS-CLARITHROMYCIN PMS
02247819 RATIO-CLARITHROMYCIN RPH
25MG/ML Suspension
02146908 BIAXIN ABB
50MG/ML Suspension
02244641 BIAXIN ABB

ERYTHROMYCIN

250MG Enteric Coated Capsule
00726672 APO-ERYTHRO APX
00607142 ERYC PFI
333MG Enteric Coated Capsule
01925938 APO-ERYTHRO APX
333MG Enteric Coated Tablet
00873454 ERYC PFI
250MG Tablet
00682020 APO-ERYTHRO BASE APX

ERYTHROMYCIN ESTOLATE

25MG/ML Suspension
00021172 NOVO-RYTHRO ESTOLATE NOP
50MG/ML Suspension
00262595 NOVO-RYTHRO ESTOLATE NOP

ERYTHROMYCIN ETHYLSUCCINATE

40MG/ML Suspension
00605859 NOVO-RYTHRO ETHYLSUCCINATE NOP
80MG/ML Suspension
00652318 NOVO-RYTHRO ETHYLSUCCINATE NOP
600MG Tablet
00637416 APO-ERYTHRO-S APX
00583782 EES-600 ABB
00704377 ERYTHRO-ES PDL

ERYTHROMYCIN STEARATE

250MG Tablet
00545678 APO-ERYTHRO-S APX
00563854 ERYTHROMYCIN PDL
02051850 NU-ERYTHROMYCIN S NXP
500MG Tablet
00688568 APO-ERYTHRO S APX
00704393 ERYTHRO PDL

08:12.16 PENICILLINS

AMOXICILLIN

250MG Capsule
00628115 APO-AMOXI APX
02238171 GEN-AMOXICILLIN GEN
02239761 MED-AMOXICILLIN MEC
00406724 NOVAMOXIN NOP
00865567 NU-AMOXI NXP
02229584 PENTA-AMOXICILLIN PEN
02230243 PMS-AMOXICILLIN PMS
00644307 PRO-AMOX PDL
02241826 SCHEIN-AMOXICILLIN SCN
500MG Capsule
00628123 APO-AMOXI APX
02238172 GEN-AMOXICILLIN GEN
02239762 MED-AMOXICILLIN MEC
00406716 NOVAMOXIN NOP
00865575 NU-AMOXI NXP
02233017 PENTA-AMOXICILLIN PEN
02230244 PMS-AMOXICILLIN PMS
00644315 PRO-AMOX PDL
02241827 SCHEIN-AMOXICILLIN SCN
125MG Chewable Tablet
02036347 NOVAMOXIN NOP
250MG Chewable Tablet
02036355 NOVAMOXIN NOP
25MG/ML Suspension
00628131 APO-AMOXI APX
00452149 NOVAMOXIN NOP
01934171 NOVAMOXIN SUGAR REDUCED NOP
00865540 NU-AMOXI NXP
02229582 PENTA-AMOXICILLIN PEN
02230245 PMS-AMOXICILLIN PMS
00644323 PRO-AMOX PDL
50MG/ML Suspension
00628158 APO-AMOXI APX
00452130 NOVAMOXIN NOP
01934163 NOVAMOXIN SUGAR REDUCED NOP
00865559 NU-AMOXI NXP
02229583 PENTA-AMOXICILLIN PEN
02230246 PMS-AMOXICILLIN PMS
00644331 PRO-AMOX PDL

AMOXICILLIN, CLAVULANIC ACID

25MG & 6.25MG/ML Suspension
02243986 APO-AMOXI CLAV APX
01916882 CLAVULIN-F 125 GSK
40MG & 5.7MG/ML Suspension
02288559 APO-AMOXI CLAV APX
02238831 CLAVULIN 200 GSK
50MG & 12.5MG/ML Suspension
02243987 APO-AMOXI CLAV APX
01916874 CLAVULIN-F 250 GSK
80MG & 11.4MG/ML Suspension
02238830 CLAVULIN 400 GSK
250MG & 125MG Tablet
02243350 APO-AMOXI CLAV APX
500MG & 125MG Tablet
02243351 APO-AMOXI CLAV APX
01916858 CLAVULIN-F GSK
02243771 RATIO-ACLAVULANATE RPH
875MG & 125MG Tablet
02245623 APO-AMOXI CLAV APX
02238829 CLAVULIN GSK
02248138 NOVO-CLAVAMOXIN NOP
02247021 RATIO-ACLAVULANATE RPH

AMPICILLIN

250MG Capsule
00020877 NOVO-AMPICILLIN NOP
500MG Capsule
00020885 NOVO-AMPICILLIN NOP
25MG/ML Suspension
00603260 APO-AMPICILLIN APX
00717495 NU-AMPI NXP
50MG/ML Suspension
00603287 APO-AMPICILLIN APX
00717649 NU-AMPI NXP
02043203 PENBRITIN WAY

CLOXACILLIN

250MG Capsule
00618292 APO-CLOXI APX
02069660 CLOXACILLINE PRO
00337765 NOVO-CLOXIN NOP
00717584 NU-CLOXI NXP
500MG Capsule
00618284 APO-CLOXI APX
02069679 CLOXACILLINE PRO
00337773 NOVO-CLOXIN NOP
00717592 NU-CLOXI NXP
25MG/ML Suspension
00644633 APO-CLOXI APX
00337757 NOVO-CLOXIN NOP
00717630 NU-CLOXI NXP

PENICILLIN V BENZATHINE

36MG/ML Suspension
02229618 PEN VEE PED
60MG/ML Suspension
02229617 PEN VEE PED

PENICILLIN V POTASSIUM

25MG/ML Suspension
00642223 APO-PEN VK APX
60MG/ML Suspension
00642231 APO-PEN VK APX
00391603 NOVO-PEN VK NOP
300MG Tablet
00642215 APO-PEN VK APX
00021202 NOVO-PEN VK NOP
00717568 NU-PEN VK NXP
00468029 PENICILLINE V PDL

PIVAMPICILLIN

35MG/ML Suspension
00582239 PONDOCILLIN LEO
500MG Tablet
00582247 PONDOCILLIN LEO

PIVMECILLINAM HCL

200MG Tablet
00657212 SELEXID LEO

08:12.18 QUINOLONES

CIPROFLOXACIN HCL

250MG Tablet
02229521 APO-CIPROFLOX APX
02155958 CIPRO BAY
02251752 CIPROFLOXCIN PDL
02247339 CO-CIPROFLOXACIN COB
02251272 DOM-CIPROFLOXACIN DPC
02245647 GEN-CIPROFLOXACIN GEN
02161737 NOVO-CIPROFLOXACIN NOP
02249634 NU-CIPROFLOXACIN NXP
02251310 PHL-CIPROFLOXACIN PHH
02248437 PMS-CIPROFLOXACIN PMS
02249960 PREM-CIPROFLOXACIN PRE
02317796 PRO-CIPROFLOXACIN PDL
02303728 RAN-CIPROFLOX RBY
02267934 RAN-CIPROFLOXACIN RBY
02246825 RATIO-CIPROFLOXACIN RPH
02251221 RIVA-CIPROFLOXACIN RIV
02248756 SANDOZ-CIPROFLOXACIN SDZ
02266962 TARO-CIPROFLOXACIN TAR
500MG Tablet
02229522 APO-CIPROFLOX APX
02155966 CIPRO BAY
02251760 CIPROFLOXACIN PDL
02247340 CO-CIPROFLOXACIN COB
02251280 DOM-CIPROFLOXACIN DPC
02245648 GEN-CIPROFLOXACIN GEN
02161745 NOVO-CIPROFLOXACIN NOP
02249642 NU-CIPROFLOXACIN NXP
02251329 PHL-CIPROFLOXACIN PHH
02248438 PMS-CIPROFLOXACIN PMS
02249979 PREM-CIPROFLOXACIN PRE
02317818 PRO-CIPROFLOXACIN PDL
02303736 RAN-CIPROFLOX RBY
02267942 RAN-CIPROFLOXACIN RBY
02246826 RATIO-CIPROFLOXACIN RPH
02248757 RHOXAL-CIPROFLOXACIN RHO
02251248 RIVA-CIPROFLOXACIN RIV
02266970 TARO-CIPROFLOXACIN TAR
750MG Tablet
02229523 APO-CIPROFLOX APX
02155974 CIPRO BAY
02251779 CIPROFLOXACIN PDL
02247341 CO-CIPROFLOXACIN COB
02251299 DOM-CIPROFLOXACIN DPC
02245649 GEN-CIPROFLOXACIN GEN
02161753 NOVO-CIPROFLOXACIN NOP
02249650 NU-CIPROFLOXACIN NXP
02251337 PHL-CIPROFLOXACIN PHH
02248439 PMS-CIPROFLOXACIN PMS
02249987 PREM-CIPROFLOXACIN PRE
02303744 RAN-CIPROFLOX RBY
02267950 RAN-CIPROFLOXACIN RBY
02246827 RATIO-CIPROFLOXACIN RPH
02248758 RHOXAL-CIPROFLOXACIN RHO
02251256 RIVA-CIPROFLOXACIN RIV

NALIDIXIC ACID

500MG Tablet
02017687 NEGGRAM SAC

NORFLOXACIN

400MG Tablet
02229524 APO-NORFLOX APX
02269627 CO-NORFLOXACIN COB
02237682 NOVO-NORFLOXACIN NOP
02239670 PDL-NORFLOXACINE PDL
02246596 PMS-NORFLOXACIN PMS
02241483 RIVA-NORFLOXACIN RIV
02301504 RIVA-NORFLOXACIN RIV

OFLOXACIN

200MG Tablet
02231529 APO-OFLOX APX
02243474 NOVO-OFLOXACIN NOP
300MG Tablet
02231531 APO-OFLOX APX
02243475 NOVO-OFLOXACIN NOP
400MG Tablet
02231532 APO-OFLOX APX
02243476 NOVO-OFLOXACIN NOP

08:12.20 SULFONAMIDES

SULFAMETHOXAZOLE

500MG Tablet
00421480 APO-SULFAMETHOXAZOLE APX

SULFAMETHOXAZOLE, TRIMETHOPRIM

40MG & 8MG/ML Suspension
00846465 APO-SULFATRIM APX
00726540 NOVO-TRIMEL NOP
00865753 NU-COTRIMOX NXP
100MG & 20MG Tablet
00445266 APO-SULFATRIM PED APX
400MG & 80MG Tablet
00445274 APO-SULFATRIM APX
00510637 NOVO-TRIMEL NOP
00865710 NU-COTRIMOX NXP
00512516 PROTRIN PDL
800MG & 160MG Tablet
00445282 APO-SULFATRIM DS APX
00510645 NOVO-TRIMEL DS NOP
00865729 NU-COTRIMOX DS NXP
00512524 PROTRIN DF PRO

SULFASALAZINE

500MG Enteric Coated Tablet
00598488 PMS-SULFASALAZINE PMS
02064472 SALAZOPYRIN PFI
500MG Tablet
00598461 PMS-SULFASALAZINE PMS
02064480 SALAZOPYRIN PFI

08:12.24 TETRACYCLINES

DOXYCYCLINE

100MG Capsule
00740713 APO-DOXY APX
00817120 DOXYCIN RIV
00742562 DOXYCYCLINE PDL
00725250 NOVO-DOXYLIN NOP
02044668 NU-DOXYCYCLINE NXP
02289539 PMS-DOXYCYCLINE PMS
02093103 RATIO-DOXYCYCLINE RPH
100MG Tablet
00874256 APO-DOXY APX
00860751 DOXYCIN RIV
00887064 DOXYTAB PDL
02158574 NOVO-DOXYLIN NOP
02044676 NU-DOXYCYCLINE NXP
02289466 PMS-DOXYCYCLINE PMS
02091232 RATIO-DOXYCYCLINE RPH
00578452 VIBRA-TABS PFI

MINOCYCLINE HCL

Limited use benefit (prior approval required).

For:

  1. patients who cannot tolerate other tetracyclines.
  2. patients with severe widespread acne who have failed on tetracycline.
50MG Capsule
02084090 APO-MINOCYCLINE APX
02239667 DOM-MINOCYCLINE DPC
02237875 MED-MINOCYCLINE MEC
02173514 MINOCIN STI
02108143 NOVO-MINOCYCLINE NOP
02153394 PDL-MINOCYCLINE PDL
02294419 PMS-MINOCYCLINE PMS
02239238 PMS-MINOCYCLINE PMS
01914138 RATIO-MINOCYCLINE RPH
02242080 RIVA-MINOCYCLINE RIV
02237313 SANDOZ-MINOCYCLINE SDZ
100MG Capsule
02084104 APO-MINOCYCLINE APX
02239668 DOM-MINOCYCLINE DPC
02237876 MED-MINOCYCLINE MEC
02173506 MINOCIN STI
02239982 MINOCYCLINE IVX
02108151 NOVO-MINOCYCLINE NOP
02154366 PDL-MINOCYCLINE PDL
02294427 PMS-MINOCYCLINE PMS
02239239 PMS-MONOCYCLINE PMS
01914146 RATIO-MINOCYCLINE RPH
02242081 RIVA-MINOCYCLINE RIV
02237314 SANDOZ-MINOCYCLINE SDZ

TETRACYCLINE HCL

250MG Capsule
00580929 APO-TETRA APX
00156744 TETRACYCLINE PRO
250MG Tablet
00717606 NU-TETRA NXP

08:12.28 MISCELLANEOUS ANTIBIOTICS

CLINDAMYCIN HCL

150MG Capsule
02245232 APO-CLINDAMYCIN APX
02248525 CLINDAMYCINE PDL
00030570 DALACIN C PFI
02258331 GEN-CLINDAMYCIN GEN
02241709 NOVO-CLINDAMYCIN NOP
02294826 PMS-CLINDAMYCIN PMS
02130033 RATIO-CLINDAMYCIN RPH
02242409 RIVA-CLINDAMYCIN RIV
300MG Capsule
02245233 APO-CLINDAMYCIN APX
02248526 CLINDAMYCINE PDL
02182866 DALACIN C PFI
02258358 GEN-CLINDAMYCIN GEN
02241710 NOVO-CLINDAMYCIN NOP
02294834 PMS-CLINDAMYCIN PMS
02192659 RATIO-CLINDAMYCIN RPH
02242410 RIVA-CLINDAMYCIN RIV

CLINDAMYCIN PALMITATE HCL

15MG/ML Solution
00225851 DALACIN C PFI

FUSIDATE SODIUM

250MG Tablet
01934252 FUCIDIN FC LEO

LINEZOLID

Limited use benefit (prior approval required).

Tablets:

For treatment of proven vancomycin-resistant enterococci (VRE) infections when other antibiotics are not available, and for the treatment of proven Methicillin-Resistant Staphylococcus aureus (MRSA) infections in patients who cannot tolerate or who had an idiosyncratic reaction with Vancomycin.

I.V. solution:

When linezolid cannot be administered orally in the above mentioned situations.

2MG/ML Injection
02243685 ZYVOXAM PFI
600MG Tablet
02243684 ZYVOXAM PFI

08:14.04 ALLYLAMINES

TERBINAFINE HCL

250MG Tablet
02239893 APO-TERBINAFINE APX
02254727 CO-TERBINAFINE COB
02242503 GEN-TERBINAFINE GEN
02031116 LAMISIL NVR
02240346 NOVO-TERBINAFINE NOP
02248845 NU-TERBINAFINE NXP
02240807 PMS-TERBINAFINE PMS
02262924 RIVA-TERBINAFINE RIV
02262177 SANDOZ-TERBINAFINE SDZ

08:14.08 AZOLES

FLUCONAZOLE

150MG Capsule
02241895 APO-FLUCONAZOLE APX
02141442 DIFLUCAN PFI
02245697 GEN-FLUCONAZOLE GEN
02243645 NOVO-FLUCONAZOLE NOP
02246620 PMS-FLUCONAZOLE PMS
02282348 PMS-FLUCONAZOLE PMS
02310694 PRO-FLUCONAZOLE PDL
02255510 RIVA-FLUCONAZOLE RIV
10MG/ML Suspension
02024152 DIFLUCAN PFI
50MG Tablet
02237370 APO-FLUCONAZOLE APX
00891800 DIFLUCAN PFI
02245292 GEN-FLUCONAZOLE GEN
02236978 NOVO-FLUCONAZOLE NOP
02245643 PMS-FLUCONAZOLE PMS
02249294 TARO-FLUCONAZOLE TAR
100MG Tablet
02237371 APO-FLUCONAZOLE APX
02245293 GEN-FLUCONAZOLE GEN
02236979 NOVO-FLUCONAZOLE NOP
02245644 PMS-FLUCONAZOLE PMS
02310686 PRO-FLUCONAZOLE PDL
02271516 RIVA-FLUCONAZOLE RIV
02249308 TAR0-FLUCONAZOLE TAR

ITRACONAZOLE

100MG Capsule
02047454 SPORANOX JNO
10MG/ML Solution
02231347 SPORANOX JNO

KETOCONAZOLE

200MG Tablet
02237235 APO-KETOCONAZOLE APX
02231061 NOVO-KETOCONAZOLE NOP
02122197 NU-KETOCON NXP

VORICONAZOLE

Limited use benefit (prior approval required).

For the treatment of:

  1. patients with invasive aspergillosis.
  2. culture proven invasive candidiasis with documented resistance to fluconazole.
50MG Tablet
02256460 VFEND PFI
200MG Tablet
02256479 VFEND PFI

08:14.28 POLYENES

NYSTATIN

100,000U/ML Suspension
02125145 DOM-NYSTATIN DPC
00792667 PMS-NYSTATIN PMS
02194201 RATIO-NYSTATIN RPH
500,000U Tablet
02194198 RATIO-NYSTATIN RPH

08:16.04 ANTITUBERCULOSIS AGENTS

ETHAMBUTOL HCL

100MG Tablet
00247960 ETIBI VAE
400MG Tablet
00247979 ETIBI VAE

ISONIAZID

10MG/ML Syrup
00265500 ISOTAMINE VAE
00577812 PMS-ISONIAZID PMS
50MG Tablet
00577782 PMS-ISONIAZID PMS
300MG Tablet
00272655 ISOTAMINE VAE
00577804 PMS-ISONIAZID PMS

PYRAZINAMIDE

500MG Tablet
00618810 PMS-PYRAZINAMIDE PMS
00283991 TEBRAZID VAE

RIFABUTIN

150MG Capsule
02063786 MYCOBUTIN PFI

RIFAMPIN

150MG Capsule
02091887 RIFADIN SAC
00393444 ROFACT VAE
300MG Capsule
02092808 RIFADIN SAC
00210463 RIMACTANE NVR
00343617 ROFACT VAE

08:18.04 ADAMANTANES

AMANTADINE HCL

100MG Capsule
02130963 DOM-AMANTADINE DPC
02034468 ENDANTADINE LIN
02139200 GEN-AMANTADINE GEN
02199289 MED-AMANTADINE MEC
01990403 PMS-AMANTADINE PMS
10MG/ML Syrup
02130971 DOM-AMANTADINE DPC
02022826 PMS-AMANTADINE PMS
01913999 SYMMETREL BMS

08:18.08 ANTIRETROVIRALS

ABACAVIR

20MG/ML Oral Liquid
02240358 ZIAGEN GSK
300MG Tablet
02240357 ZIAGEN GSK

ABACAVIR, LAMIVUDINE

600MG & 300MG Tablet
02269341 KIVEXA GSK

ABACAVIR, LAMIVUDINE, ZIDOVUDINE

300MG & 150MG & 300MG Tablet
02244757 TRIZIVIR GSK

AMPRENAVIR

Limited use benefit (prior approval required).

For the management of HIV disease in patients who have failed other protease inhibitor combinations, or for patients who experienced a lack of tolerability to other protease inhibitors.

50MG Capsule
02243541 AGENERASE GSK
150MG Capsule
02243542 AGENERASE GSK
15MG/ML Oral Liquid
02243543 AGENERASE GSK

ATAZANAVIR SULFATE

150MG Capsule
02248610 REYATAZ BMS
200MG Capsule
02248611 REYATAZ BMS
300MG Capsule
02294176 REYATAZ BMS

DARUNAVIR

Limited use benefit (prior approval required).

For the management of HIV in patients who failed or have experienced adverse events to three or more listed protease inhibitors.

300MG Tablet
02284057 PREZISTA JNO

DIDANOSINE

125MG Capsule
02244596 VIDEX EC BMS
200MG Capsule
02244597 VIDEX EC BMS
250MG Capsule
02244598 VIDEX EC BMS
400MG Capsule
02244599 VIDEX EC BMS

EFAVIRENZ

50MG Capsule
02239886 SUSTIVA BMS
100MG Capsule
02239887 SUSTIVA BMS
200MG Capsule
02239888 SUSTIVA BMS
600MG Tablet
02246045 SUSTIVA BMS

EFAVIRENZ, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE

Limited use benefit (prior approval required).

For the treatment of HIV-1 infection adults where the virus is susceptible to each of tenofovir, emtricitabine and efavirenz, and:

  1. Atripla is used to replace existing therapy with its component drugs, or
  2. the patient is treatment naïve, or
  3. the patient has established viral suppression but requires antiretroviral therapy modification due to intolerance or adverse effects.

Note: Criteria will be confirmed against medication history.

600MG/200MG/300MG Tablet
02300699 ATRIPLA BMS

EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE

Limited use benefit (prior approval required).

For the treatment of patients with HIV infection where the virus is susceptible to both emtricitabine and tenofovir AND where the triple-entity antiretroviral agent (tenofovir/ emtricitabine/efavirenz) is not indicated due to one of the following:

  1. efavirenz resistance;
  2. adverse effects secondary to efavirenz.
200MG/300MG Tablet
02274906 TRUVADA GIL

FOSAMPRENAVIR CALCIUM

50MG/ML Oral Suspension
02261553 TELZIR GSK
700MG Tablet
02261545 TELZIR GSK

INDINAVIR SULFATE

200MG Capsule
02229161 CRIXIVAN FRS
400MG Capsule
02229196 CRIXIVAN FRS

LAMIVUDINE

10MG/ML Solution
02192691 3TC GSK
100MG Tablet
02239193 HEPTOVIR GSK
150MG Tablet
02192683 3TC GSK
300MG Tablet
02247825 3TC GSK

LAMIVUDINE, ZIDOVUDINE

150MG & 300MG Tablet
02239213 COMBIVIR GSK

LOPINAVIR, RITONAVIR

80MG & 20MG/ML Oral Solution
02243644 KALETRA ABB
100MG & 25MG Tablet
02312301 KALETRA ABB
200MG & 50MG Tablet
02285533 KALETRA ABB

NELFINAVIR MESYLATE

50MG/G Powder for Suspension
02238618 VIRACEPT PFI
250MG Tablet
02238617 VIRACEPT PFI
625MG Tablet
02248761 VIRACEPT PFI

NEVIRAPINE

200MG Tablet
02238748 VIRAMUNE BOE

RALTEGRAVIR

Limited use benefit (prior approval required).

For the treatment of HIV infection in patients who are antiretroviral experienced and have virologic failure due to resistance to at least one agent from each of the three major classes of antiretroviral agents, nucleoside/tide reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors and protease inhibitors.

400MG Tablet
02301881 ISENTRESS FRS

RITONAVIR

100MG Capsule
02241480 NORVIR SEC ABB
80MG/ML Liquid
02229145 NORVIR ABB

SAQUINAVIR MESYLATE

200MG Capsule
02216965 INVIRASE HLR
500MG Tablet
02279320 INVIRASE HLR

STAVUDINE

15MG Capsule
02216086 ZERIT BMS
20MG Capsule
02216094 ZERIT BMS
30MG Capsule
02216108 ZERIT BMS
40MG Capsule
02216116 ZERIT BMS

TENOFOVIR DISOPROXIL FUMARATE

Limited use benefit (prior approval required).

For the management of HIV disease in patients who have failed or have experienced adverse events to an alternative nucleoside reverse transcriptase inhibitor.

245MG Tablet
02247128 VIREAD GIL

TIPRANAVIR

Limited use benefit (prior approval required).

For the management of HIV disease in patients

  1. who have failed all currently listed protease inhibitors
  2. intolerant to all currently listed protease inhibitors
250MG Capsule
02273322 APTIVUS BOE

ZIDOVUDINE

100MG Capsule
01946323 APO-ZIDOVUDINE APX
01902660 RETROVIR GSK
10MG/ML Syrup
01902652 RETROVIR GSK

08:18.20 INTERFERONS

PEGINTERFERON ALFA-2A

Limited use benefit (prior approval required).

For the treatment of chronic hepatitis C in patients who are treatment naïve, upon the written request of a hepatologist or other specialist in this area.

  1. For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved. A further 24 week supply may be approved if patient has a viral reduction of at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
  2. For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will be approved. Renewals will not be covered
180MCG/0.5ML Injection
02248077 PEGASYS HLR
180MCG/1ML Injection
02248078 PEGASYS HLR

PEGINTERFERON ALFA-2A, RIBAVIRIN

Limited use benefit (prior approval required).

For the treatment of chronic hepatitis C in patients who are treatment naïve, upon the written request of a hepatologist or other specialist in this area.

  1. For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved. A further 24 week supply may be approved if patient has a viral reduction of at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
  2. For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will be approved. Renewals will not be covered
180MCG/0.5ML & 200MG Injection & Tablet
02253429 PEGASYS RBV HLR
180MCG/1ML & 200MG Injection & Tablet
02253410 PEGASYS RBV HLR

PEGINTERFERON ALFA-2B

Limited use benefit (prior approval required).

For the treatment of chronic hepatitis C in patients who are treatment naïve, upon the written request of a hepatologist or other specialist in this area.

  1. For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved. A further 24 week supply may be approved if patient has a viral reduction of at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
  2. For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will be approved. Renewals will not be covered
74MCG/VIAL Injection
02242966 UNITRON PEG SCH
118.4MCG/VIAL Injection
02242967 UNITRON PEG SCH
177.6MCG/VIAL Injection
02242968 UNITRON PEG SCH
222MCG/VIAL Injection
02242969 UNITRON PEG SCH

PEGINTERFERON ALFA-2B, RIBAVIRIN

Limited use benefit (prior approval required).

For the treatment of chronic hepatitis C in patients who are treatment naïve, upon the written request of a hepatologist or other specialist in this area.

  1. For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved. A further 24 week supply may be approved if patient has a viral reduction of at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
  2. For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will be approved. Renewals will not be covered
50MCG/0.5ML & 200MG Injection & Capsule
02246026 PEGETRON SCH
02254573 PEGETRON REDIPEN SCH
80MCG/0.5ML & 200MG Injection & Capsule
02246027 PEGETRON SCH
02254581 PEGETRON REDIPEN SCH
100MCG/0.5ML & 200MG Injection & Capsule
02246028 PEGETRON SCH
02254603 PEGETRON REDIPEN SCH
120MCG/0.5ML & 200MG Injection & Capsule
02246029 PEGETRON SCH
02254638 PEGETRON REDIPEN SCH
150MCG/0.5ML & 200MG Injection & Capsule
02246030 PEGETRON SCH
02254646 PEGETRON REDIPEN SCH

08:18.32 NUCLEOSIDES AND NUCLEOTIDES

ACYCLOVIR

40MG/ML Suspension
00886157 ZOVIRAX GSK
200MG Tablet
02207621 APO-ACYCLOVIR APX
02242784 GEN-ACYCLOVIR GEN
02285959 NOVO-ACYCLOVIR NOP
02197405 NU-ACYCLOVIR NXP
02237541 PDL-ACYCLOVIR PDL
02078627 RATIO-ACYCLOVIR RPH
00634506 ZOVIRAX GSK
400MG Tablet
02207648 APO-ACYCLOVIR APX
02242463 GEN-ACYCLOVIR GEN
02285967 NOVO-ACYCLOVIR NOP
02197413 NU-ACYCLOVIR NXP
02237542 PDL-ACYCLOVIR PDL
02078635 RATIO-ACYCLOVIR RPH
01911627 ZOVIRAX GSK
800MG Tablet
02207656 APO-ACYCLOVIR APX
02242464 GEN-ACYCLOVIR GEN
02285975 NOVO-ACYCLOVIR NOP
02197421 NU-ACYCLOVIR NXP
02237543 PDL-ACYCLOVIR PDL
02078651 RATIO-ACYCLOVIR RPH
01911635 ZOVIRAX GSK

ADEFOVIR DIPIVOXIL

Limited use benefit (prior approval required).

For the treatment of chronic hepatitis B infection when used in combination with lamivudine in patients who have developed failure to lamivudine, as defined by an increase in HBV DNA of ≥ 1 log10 IU/mL above the nadir, measured on two separate occasions within an interval of at least one month, after the first three months of lamivudine therapy, and when failure to lamivudine is not due to poor adherence to therapy.

10MG Tablet
02247823 HEPSERA GIL

ENTECAVIR

Limited use benefit (prior approval required).

For the treatment of chronic hepatitis B infection in patients with cirrhosis documented on radiologic or histologic grounds and a HBV DNA concentration above 2000IU/mL.

0.5MG Tablet
02282224 BARACLUDE BMS

FAMCICLOVIR

125MG Tablet
02292025 APO-FAMCICLOVIR APX
02305682 CO FAMCICLOVIR COB
02229110 FAMVIR NVR
02278081 PMS-FAMCICLOVIR PMS
02278634 SANDOZ-FAMCICLOVIR SDZ
250MG Tablet
02292041 APO-FAMCICLOVIR APX
02305690 CO FAMCICLOVIR COB
02229129 FAMVIR NVR
02278103 PMS-FAMCICLOVIR PMS
02278642 SANDOZ-FAMCICLOVIR SDZ
500MG Tablet
02292068 APO-FAMCICLOVIR APX
02305704 CO FAMCICLOVIR COB
02177102 FAMVIR NVR
02278111 PMS-FAMCICLOVIR PMS
02278650 SANDOZ-FAMCICLOVIR SDZ

GANCICLOVIR SODIUM

500MG Injection
02162695 CYTOVENE HLR

VALACYCLOVIR HCL

500MG Tablet
02295822 APO-VALACYCLOVIR APX
02298457 PMS-VALACYCLOVIR PMS
02316447 RIVA-VALACYCLOVIR RIV
02219492 VALTREX GSK

VALGANCICLOVIR HCL

450MG Tablet
02245777 VALCYTE HLR

08:30.04 AMEBICIDES

DIIODOHYDROXYQUIN

210MG Tablet
01997769 DIODOQUIN GLE
650MG Tablet
01997750 DIODOQUIN GLE

PAROMOMYCIN SULFATE

250MG Capsule
02078759 HUMATIN ERF

08:30.08 ANTIMALARIALS

CHLOROQUINE PHOSPHATE

250MG Tablet
00021261 NOVO-CHLOROQUINE NOP

HYDROXYCHLOROQUINE SULFATE

200MG Tablet
02246691 APO-HYDROXYQUINE APX
02252600 GEN-HYDROXYCHLOROQUINE GEN
02017709 PLAQUENIL SAC
02311011 PRO-HYDROXYQUINE PDL

PRIMAQUINE PHOSPHATE

26.3MG Tablet
02017776 PRIMAQUINE SAC

PYRIMETHAMINE

25MG Tablet
00004774 DARAPRIM GSK

08:30.92 MISCELLANEOUS ANTIPROTOZOALS

ATOVAQUONE

150MG/ML Suspension
02217422 MEPRON GSK

METRONIDAZOLE

500MG Capsule
02248562 APO-METRONIDAZOLE APX
00783137 TRIKACIDE PMS
250MG Tablet
00545066 APO-METRONIDAZOLE APX
00420409 METRONIDAZOLE PDL

PENTAMIDINE ISETHIONATE

300MG/VIAL Injection
02183080 PENTAMIDINE MAY

TRIMETREXATE GLUCURONATE

25MG/VIAL Injection
02065770 NEUTREXIN MIO

08:36.00 URINARY ANTI-INFECTIVES

NITROFURANTOIN

50MG Capsule
01997637 MACRODANTIN PGP
02231015 NOVO-FURANTOIN NOP
100MG Capsule
02063662 MACROBID PGP
02231016 NOVO-FURANTOIN NOP
50MG Tablet
00319511 APO-NITROFURANTOIN APX
100MG Tablet
00312738 APO-NITROFURANTOIN APX

TRIMETHOPRIM

100MG Tablet
02243116 APO-TRIMETHOPRIM APX
200MG Tablet
02243117 APO-TRIMETHOPRIM APX